Transcranial optical imaging reveals a pathway for optimizing the delivery of immunotherapeutics to the brain
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Despite the initial promise of immunotherapy for CNS disease, multiple recent clinical trials have failed. This may be due in part to characteristically low penetration of antibodies to cerebrospinal fluid (CSF) and brain parenchyma, resulting in poor target engagement. We here utilized transcranial macroscopic imaging to noninvasively evaluate in vivo delivery pathways of CSF fluorescent tracers. Tracers in CSF proved to be distributed through a brain-wide network of periarterial spaces, previously denoted as the glymphatic system. CSF tracer entry was enhanced approximately 3-fold by increasing plasma osmolality without disruption of the blood-brain barrier. Further, plasma hyperosmolality overrode the inhibition of glymphatic transport that characterizes the awake state and reversed glymphatic suppression in a mouse model of Alzheimer's disease. Plasma hyperosmolality enhanced the delivery of an amyloid-β (Aβ) antibody, obtaining a 5-fold increase in antibody binding to Aβ plaques. Thus, manipulation of glymphatic activity may represent a novel strategy for improving penetration of therapeutic antibodies to the CNS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Self-citationSleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411
Self-citationThe antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059 · cited 4×
“Tracer and antibody penetration were also quantified ex vivo in coronal sections, as described previously (1).”
InfluentialThe glymphatic system: a beginner's guide
Jessen, N. A., Munk, A. S. F., Lundgaard, I., & Nedergaard, M. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1581-6 · Cited by 2,075
Self-citationTwo Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312889 · Cited by 1,668 · cited 1×
“than the concentration needed to achieve adequate binding of the target antigen in peripheral tissues (1, 17), and these high doses in clinical trials increase the prevalence of adverse events (1, 9, 18) such as amyloid-related imaging abnormalities (ARIA) (19, 20).”
Impairment of paravascular clearance pathways in the aging brain
Kress, B. T., Iliff, J. J., Xia, M., Wang, M., Wei, H. S., Zeppenfeld, D., Xie, L., Kang, H., Xu, Q., Liew, J. A., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24271 · Cited by 1,521 · cited 4×
“While the role of the glymphatic pathway both in the clearance (21, 28, 29, 38, 41, 42) and delivery (21, 39, 43–48) of solutes has been established by multiple groups, prior studies using fluorescent, radiolabeled, and gadolinium-based tracers also suggest that convective flow through this pathway might be exploited…”
InfluentialSelf-citationCerebral Arterial Pulsation Drives Paravascular CSF–Interstitial Fluid Exchange in the Murine Brain
Iliff, J. J., Wang, M., Zeppenfeld, D. M., Venkataraman, A., Plog, B. A., Liao, Y., Deane, R., & Nedergaard, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1592-13.2013 · Cited by 1,319 · cited 2×
“The fast, convective fluid flow within the glymphatic system effectively delivers solutes of high-molecular weight (21) but is strongly regulated by brain state (28), aging (29), arterial pulsatility (30), and body posture (31).”
Self-citationBrain-wide pathway for waste clearance captured by contrast-enhanced MRI
Iliff, J. J., Lee, H., Yu, M., Feng, T., Logan, J., Nedergaard, M., & Benveniste, H. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67677 · Cited by 1,148
Self-citation
Research works printed but not linked: 28
- 10.1002/mds.26878 · DOI · Paper page
- Gros-Louis, 2010, Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS, J Neurochem, 113, 1188, 10.1111/j.1471-4159.2010.06683.x · DOI · Paper page
- Gallardo, 2017, Antibody therapeutics targeting Aβ and Tau, Cold Spring Harb Perspect Med, 7, 10.1101/cshperspect.a024331 · DOI · Paper page
- 10.1200/JCO.2017.72.8089 · DOI · Paper page
- 10.1016/j.pharmthera.2014.05.009 · DOI · Paper page
- 10.1016/j.pediatrneurol.2016.10.022 · DOI · Paper page
- 10.1186/alzrt220 · DOI · Paper page
- 10.1016/S0196-9781(02)00261-9 · DOI · Paper page
- 10.1016/j.expneurol.2007.05.005 · DOI
- Salloway, 2014, Phase 3 trials of solanezumab and bapineuzumab for Alzheimer’s disease, N Engl J Med, 370
- Rennels, 1990, Rapid solute transport throughout the brain via paravascular fluid pathways, Adv Neurol, 52, 431
- 10.1016/j.jconrel.2014.10.034 · DOI · Paper page
- Pullen, 1987, Bulk flow of cerebrospinal fluid into brain in response to acute hyperosmolality, Am J Physiol, 253, F538
- Cserr, 1987, Volume regulatory influx of electrolytes from plasma to brain during acute hyperosmolality, Am J Physiol, 253, F530
- 10.1177/0271678X16661202 · DOI · Paper page
- 10.1186/s13024-016-0138-8 · DOI · Paper page
- Rangroo Thrane, 2013, Paravascular microcirculation facilitates rapid lipid transport and astrocyte signaling in the brain, Sci Rep, 3
- 10.1016/j.neurobiolaging.2016.11.002 · DOI · Paper page
- 10.1161/STROKEAHA.114.006617 · DOI · Paper page
- Brain Trauma Foundation, 2007, Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy, J Neurotrauma, 24 Suppl 1, S14
- 10.1177/0271678X16655550 · DOI · Paper page
- Muizelaar, 1984, Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients, J Neurosurg, 61, 700, 10.3171/jns.1984.61.4.0700 · DOI · Paper page
- Domaingue, 1985, Hypotensive effect of mannitol administered rapidly, Anaesth Intensive Care, 13, 134, 10.1177/0310057X8501300204 · doi:10.1177/0310057x8501300204
- 10.1186/alzrt233 · DOI · Paper page
- 10.1063/1.4979668 · DOI
- 10.1016/j.jneumeth.2016.04.012 · DOI · Paper page
- 10.1038/nmeth.2089 · DOI · Paper page
- 10.1038/nmeth.2019 · DOI · Paper page
Cited by
Aquaporin-4-dependent glymphatic solute transport in the rodent brain
Mestre, H., Hablitz, L. M., Xavier, A. L., Feng, W., Zou, W., Pu, T., Monai, H., Murlidharan, G., Castellanos Rivera, R. M., Simon, M. J., et al. (2018) · eLife · doi:10.7554/elife.40070 · Cited by 738
Self-citationCircadian control of brain glymphatic and lymphatic fluid flow
Hablitz, L. M., Plá, V., Giannetto, M., Vinitsky, H. S., Stæger, F. F., Metcalfe, T., Nguyen, R., Benrais, A., & Nedergaard, M. (2020) · Nature Communications · doi:10.1038/s41467-020-18115-2 · Cited by 704
Self-citationThe Brain’s Glymphatic System: Current Controversies
Mestre, H., Mori, Y., & Nedergaard, M. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.04.003 · Cited by 609
Self-citationRasmussen, M. K., Mestre, H., & Nedergaard, M. (2022) · Physiological Reviews · doi:10.1152/physrev.00031.2020 · Cited by 597
Self-citationCerebrospinal fluid influx drives acute ischemic tissue swelling
Mestre, H., Du, T., Sweeney, A. M., Liu, G., Samson, A. J., Peng, W., Mortensen, K. N., Stæger, F. F., Bork, P. A. R., Bashford, L., et al. (2020) · Science · doi:10.1126/science.aax7171 · Cited by 494
Self-citation
Metadata
- Authors
- Plog, B. A., Mestre, H., Olveda, G. E., Sweeney, A. M., Kenney, H. M., Cove, A., Dholakia, K. Y., Tithof, J., Nevins, T. D., Lundgaard, I., Du, T., Kelley, D. H., & Nedergaard, M.
- Venue
- JCI Insight
- Published
- 2018-10-18
- Volume
- 3
- Issue
- 20
- ISSN
- 2379-3708 (ISSN-L)
- OpenAlex
- W2896444937
- Cited by
- 101
- References
- 33
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- National Institutes of Health (5R01NS100366-02, 1RF1AG057575-01)
- U.S. Department of Defense (Science,Engineering Graduate Fellowship)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transcranial optical imaging reveals a pathway for optimizing the delivery of immunotherapeutics to the brain. https://app.cochat.ai/papers/10.1172/jci.insight.120922
- The paper
- Plog, B. A., Mestre, H., Olveda, G. E., Sweeney, A. M., Kenney, H. M., Cove, A., Dholakia, K. Y., Tithof, J., Nevins, T. D., Lundgaard, I., Du, T., Kelley, D. H., & Nedergaard, M. (2018). Transcranial optical imaging reveals a pathway for optimizing the delivery of immunotherapeutics to the brain. JCI Insight. https://doi.org/10.1172/jci.insight.120922
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.